Periodontal Osseous Wall Piezosplitting and EDTA Root Surface Etching

February 13, 2023 updated by: mahmoud eldestawy, Al-Azhar University

A Novel Approach of Periodontal Osseous Wall Piezosplitting and EDTA Root Surface Etching in Management of Localized Intrabony Defects With Wide Angulation. Controlled Clinical Trial

This study was designed to investigate the use of minimally invasive Piezo knife to harvest vascularized interceptal bone pedicle in treating intrabony defects.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Sixteen non-smoking patients with severe chronic periodontitis participated in this prospective, randomized clinical study. Patients were randomly assigned into one of a 2 groups (8 patients each): bone substitute grafting of the intrabony defect, control group (Gr1), intrabony defect osseous wall swaging (OWS) combined xenograft (Gr2). In both groups root surfaces where treated with a neutral 24% EDTA gel and saline irrigation. Clinical and radiographic measurements were reassessed at 6 months after surgery.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. good compliance with plaque control instructions following initial therapy
  2. teeth involved were all vital with no mobility ;
  3. each subject contributed a single predominately 2 or 3-wall intrabony interproximal defect around premolar or molar teeth without furcation involvement;

Exclusion Criteria:

  1. no systemic diseases which could influence the outcome of therapy;
  2. absence of periodontal treatment during the previous year.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: bone swaging alone
xenograft alone
osseous wall pedicle was placed to treat the infrabony defect by autogrnous bone
EXPERIMENTAL: bone swaging plus EDTA
bone swaging with EDTA
osseous wall pedicle was placed to treat the infrabony defect by autogrnous bone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic evaluation
Time Frame: 3 months
removing the defect as seen in radiograph defect filling with bone swaging with edta and bone substitute
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical pocket depth
Time Frame: 3month
By periodontal prob to measure the clinical parameter
3month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 5, 2016

Primary Completion (ACTUAL)

January 5, 2017

Study Completion (ACTUAL)

January 5, 2017

Study Registration Dates

First Submitted

August 1, 2018

First Submitted That Met QC Criteria

September 12, 2018

First Posted (ACTUAL)

September 14, 2018

Study Record Updates

Last Update Posted (ESTIMATE)

February 14, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 839/2757

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

institutional review board, egypt

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on bone swaging

3
Subscribe